Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
November 01, 2022 08:00 ET
|
Anika Therapeutics Inc.
Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks ...
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
October 25, 2022 09:25 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release
September 12, 2022 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the limited...
Anika Reports Second Quarter Fiscal 2022 Financial Results
August 03, 2022 16:05 ET
|
Anika Therapeutics Inc.
Second quarter revenue growth up 4%X-Twist™ 510(k) clearance received; Limited market release on schedule for 2H 2022 BEDFORD, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
July 27, 2022 09:15 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has...
Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022
July 12, 2022 17:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
June 10, 2022 09:27 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio
May 20, 2022 07:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2022 17:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 2, 2022,...
Anika to Participate in the UBS Global Healthcare Conference 2022
May 09, 2022 16:05 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...